Warning: The NCBI web site requires JavaScript to function. more...
Data mining of cancer vaccine trials: a bird's-eye view.
Cao X, Maloney KB, Brusic V.
Immunome Res. 2008 Dec 12;4:7.
Related citations
Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
[No authors listed]
Drugs R D. 2006;7(3):197-201. Review.
The NCI All Ireland Cancer Conference.
Johnston PG, Daly PA, Liu E.
Oncologist. 1999;4(4):275-277.
Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
Drugs R D. 2004;5(5):305-11.
Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D. 2003;4(5):312-9. Review.
Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd.
Drugs R D. 2003;4(4):243-8.
Adding value to clinical trial registries: insights from Australian Cancer Trials Online, a website for consumers.
Dear R, Barratt A, Askie L, McGeechan K, Arora S, Crossing S, Currow D, Tattersall M.
Clin Trials. 2011 Feb;8(1):70-6.
Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D. 2005;6(3):178-85. Review.
Cancer vaccine THERATOPE- Biomira.
Drugs R D. 2003;4(4):236-40.
A clinical development paradigm for cancer vaccines and related biologics.
Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G; Cancer Vaccine Clinical Trial Working Group.
J Immunother. 2007 Jan;30(1):1-15. Review.
Cancer vaccine--Antigenics.
BioDrugs. 2002;16(1):72-4. Review.
HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen.
Drugs R D. 2003;4(4):249-53.
DNA vaccines: a review.
Lewis PJ, Babiuk LA.
Adv Virus Res. 1999;54:129-88. Review.
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.
Health Technol Assess. 2001;5(32):1-195. Review.
Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.
BioDrugs. 2003;17(1):69-72.
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D. 2007;8(3):176-87. Review.
Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.
Drugs R D. 2004;5(5):293-6.
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.
American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology.
J Clin Oncol. 2003 Jun 15;21(12):2377-86. Epub 2003 Apr 29.
Anticancer Drug Development: The Way Forward.
Connors T.
Oncologist. 1996;1(3):180-181.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on